title: Correlation of Hepatitis B surface antigen mutations with clinical status of the chronically infected patients from Kermanshah, West of Iran.
abstract: OBJECTIVE
  Hepatitis B virus (HBV) genetic and protein variations have been found in chronic HBV infected patients who did not receive any treatment and active or passive immunizations. The aims of this study were to determine the genotypes as well as the patterns of variations distribution in chronically infected patients from the west part of Iran.
  
  
  METHODS
  Forty-six people with chronic HBV infection were enrolled in the study. The surface genes were amplified, sequenced and subsequently aligned using international and national Iranian database.
  
  
  RESULTS
  All strains belonged to genotype D, subgenotype D1 and subtype ayw2. Of all 116 "mutations" that occurred at 59 nucleotide positions, 49 (42.2 %) were missense (amino acid altering) and 67 (57.7%) were silent (no amino acid changing), respectively. At the amino acid level, 38 (79.1%) out of 48 amino acid mutations occurred in different immune epitopes within the surface proteins, of which 2 (5.2%) occurred in B cell; 12 (31.5%) in T helper and 24 (63.1%) inside CTL epitopes. There were significant associations between amino acid mutations (especially within immune epitopes) and anti-HBe positivity and increased ALT levels (P values: 0.014 and 0.04, respectively).
  
  
  CONCLUSIONS
  The distribution of amino acid mutations as well as the ratio between silent and missense nucleotide mutations showed that a narrowly focused immune pressure had already been on the surface protein T cell epitopes (94.9% of mutations), particularly CTL epitopes which led to the emergence of escape mutants in these patients.
authors.affiliation: Kermanshah Liver Diseases and Hepatitis Reseaerch Center, Kermanshah Universityof Medical Sciences, Kermanshah, Iran.
authors.forename: B
authors.initials: B
authors.lastname: Sayad
authors.forename: F A
authors.initials: FA
authors.lastname: Anvari
authors.forename: S M
authors.initials: SM
authors.lastname: Alavian
authors.forename: M
authors.initials: M
authors.lastname: Norouzi
authors.forename: M
authors.initials: M
authors.lastname: Hamzelooie
authors.forename: M
authors.initials: M
authors.lastname: Shirvani
authors.forename: A
authors.initials: A
authors.lastname: Pourhoseingholi
authors.forename: A
authors.initials: A
authors.lastname: Khedive
authors.forename: S
authors.initials: S
authors.lastname: Ghamari
authors.forename: M A
authors.initials: MA
authors.lastname: Judaki
authors.forename: S M
authors.initials: SM
authors.lastname: Jazayeri
mesh_terms: D000328:Adult; D005260:Female; D005838:Genotype; D006514:Hepatitis B Surface Antigens / Q000235:genetics* / Q000276:immunology; D006515:Hepatitis B virus / Q000235:genetics* / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007492:Iran; D008297:Male; D008875:Middle Aged; D009154:Mutation; D020125:Mutation, Missense
chemical_list: D006514:Hepatitis B Surface Antigens